Antidepressants elevate GDNF expression and release from C 6 glioma cells in a β-arrestin1-dependent, CREB interactive pathway

International Journal of Neuropsychopharmacology

Volumn 14, Issue 10, 2011, Pages 1289-1300

  Golan, Moran ^a   Schreiber, Gabriel ^a,b   Avissar, Sofia ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

Author keywords

arrestin1; Antidepressants; CREB; GDNF; glial cells

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ARRESTIN; CITALOPRAM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESIPRAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HALOPERIDOL; IMIPRAMINE; LITHIUM; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FRACTIONATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; GLIOMA CELL; MAJOR DEPRESSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEROTONIN UPTAKE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ARRESTINS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CITALOPRAM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIOBLASTOMA; HALOPERIDOL; IMIPRAMINE; NEUROTRANSMITTER UPTAKE INHIBITORS; PHOSPHORYLATION; RATS; RNA INTERFERENCE; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION; VALPROIC ACID;

EID: 80055014565     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001550     Document Type: Article

References (60)

1. aan het Rot M, Mathew SJ, Charney DS (2009). Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 180, 305-313.
2. Avissar S, Matuzany-Ruban A, Tzukert K, Schreiber G (2004). Beta-arrestin-1 levels : reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. American Journal of Psychiatry 161, 2066-2072. (Pubitemid 39441408)
3. Baecker PA, Lee WH, Verity AN, Eglen RM, et al. (1999). Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene. Brain Research. Molecular Brain Research 69, 209-222. (Pubitemid 29253813)
4. Banasr M, Duman RS (2007). Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurological Disorders Drug Targets 6, 311-320. (Pubitemid 351492092)
5. Beaulieu JM, Caron MG (2005). Beta-arrestin goes nuclear. Cell 123, 755-757.
6. Castren E, Voikar V, Rantamaki T (2007). Role of neurotrophic factors in depression. Current Opinion in Pharmacology 7, 18-21. (Pubitemid 46238033)
7. Cen X, Nitta A, Ohya S, Zhao Y, et al. (2006). An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway. Journal of Neuroscience 26, 3335-3344.
8. Colvis CM, Pollock JD, Goodman RH, Impey S, et al. (2005). Epigenetic mechanisms and gene networks in the nervous system. Journal of Neuroscience 25, 10379-10389. (Pubitemid 41628442)
9. Connor B, Dragunow M (1998). The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Research. Brain Research Reviews 27, 1-39. (Pubitemid 28300281)
10. Cotter DR, Pariante CM, Everall IP (2001). Glial cell abnormalities in major psychiatric disorders : The evidence and implications. Brain Research Bulletin 55, 585-595. (Pubitemid 32888377)
11. Czeh B, Simon M, Schmelting B, Hiemke C, et al. (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31, 1616-1626. (Pubitemid 44106693)
12. David DJ, Samuels BA, Rainer Q, Wang JW, et al. (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62, 479-493.
13. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007). Beta-arrestins and cell signaling. Annual Review of Physiology 69, 483-510.
14. Donati RJ, Rasenick MM (2005). Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30, 1238-1245. (Pubitemid 40848078)
15. Donati RJ, Thukral C, Rasenick MM (2001). Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsalpha. Molecular Pharmacology 59, 1426-1432. (Pubitemid 32510107)
16. Duman RS, Newton SS (2007). Epigenetic marking and neuronal plasticity. Biological Psychiatry 62, 1-3. (Pubitemid 46898232)
17. Fishman PH, Finberg JP (1987). Effect of the tricyclic antidepressant desipramine on beta-adrenergic receptors in cultured rat glioma C6 cells. Journal of Neurochemistry 49, 282-289. (Pubitemid 17108261)
18. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, et al. (2004). Desensitization of G protein-coupled receptors and neuronal functions. Annual Review of Neuroscience 27, 107-144. (Pubitemid 39050399)
19. Golan M, Schreiber G, Avissar S (2010). Antidepressants increase beta-arrestin2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells. Journal of Pharmacology and Experimental Therapeutics 332, 970-976.
20. Gurevich VV, Gurevich EV (2003). The new face of active receptor bound arrestin attracts new partners. Structure 11, 1037-1042. (Pubitemid 37103064)
21. Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M (2008). Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells : A possible contribution to GDNF production. Brain Research 1196, 53-58.
22. Hisaoka K, Nishida A, Koda T, Miyata M, et al. (2001). Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. Journal of Neurochemistry 79, 25-34. (Pubitemid 32946639)
23. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, et al. (2007). Antidepressants increase glial cell line-derived neurotrophic factor production through monoamineindependent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. Journal of Pharmacology and Experimental Therapeutics 321, 148-157. (Pubitemid 46456986)
24. Huang EJ, Reichardt LF (2001). Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 24, 677-736. (Pubitemid 32695243)
25. Kang J, Shi Y, Xiang B, Qu B, et al. (2005). A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123, 833-847. (Pubitemid 41721030)
26. Koyama Y, Egawa H, Osakada M, Baba A, et al. (2004). Increase by FK960, a novel cognitive enhancer, in glial cell line-derived neurotrophic factor production in cultured rat astrocytes. Biochemical Pharmacology 68, 275-282. (Pubitemid 38757696)
27. Kristen LP, Lefkowitz RJ (2001). Classical and new roles of b-arrestin in the regulation of G-protein-coupled receptors. Nature Reviews 2, 727-730.
28. Lefkowitz RJ (2004). Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences 25, 413-422. (Pubitemid 38981557)
29. Lefkowitz RJ, Shenoy SK (2005). Transduction of receptor signals by b-arrestins. Science 308, 512-517.
30. Lefkowitz RJ, Whalen EJ (2004). b-arrestins : traffic cops of cell signaling. Current Opinion in Cell Biology 16, 162-168. (Pubitemid 38757292)
31. Leventopoulos M, Ruedi-Bettschen D, Knuesel I, Feldon J, et al. (2007). Long-term effects of early life deprivation on brain glia in Fischer rats. Brain Research 1142, 119-126. (Pubitemid 46413198)
32. Lin LF, Doherty DH, Lile JD, Bektesh S, et al. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132. (Pubitemid 23186789)
33. Liu Q, Li B, Zhu HY, Wang YQ, et al. (2009). Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression. European Neuropsychopharmacology 19, 796-805.
34. Lohse MJ, Benovic JL, Codina J, Caron MG, et al. (1990). Beta-Arrestin : A protein that regulates beta-adrenergic receptor function. Science 248, 1547-1550.
35. Lonze BE, Ginty DD (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623. (Pubitemid 35229980)
36. Luttrell LM, Lefkowitz RJ (2002). The role of beta-arrestins in the termination and transduction of G-protein coupled receptor signals Journal of Cell Science 115, 455-465.
37. Ma L, Pei G (2007). Beta-arrestin signaling and regulation of transcription. Journal of Cell Science 120, 213-218.
38. Maes M, Meltzer HY (1995). The serotonin hypothesis of major depression. In : Bloom FE, Kupfer DJ (Eds), Psychopharmacology : The Fourth Generation of Progress (pp. 933-944), New York: Raven Press.
39. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG (1999). Energy on demand. Science 283, 496-497.
40. Matuzany-Ruban A, Avissar S, Schreiber G (2005). Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in MNL of patients with depression. Journal of Affective Disorders 88, 307-312. (Pubitemid 41446972)
41. Mercier G, Lennon AM, Renouf B, Dessouroux A, et al. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. Journal of Molecular Neuroscience 24, 207-216. (Pubitemid 41359148)
42. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, et al. (2002). Neurobiology of depression. Neuron 34, 13-25. (Pubitemid 34270695)
43. Oh-hashi K, Kaneyama M, Hirata Y, Kiuchi K (2006). ER calcium discharge stimulates GDNF gene expression through MAPK-dependent and -independent pathways in rat C6 glioblastoma cells. Neuroscience Letters 405, 100-105. (Pubitemid 44142819)
44. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290-13295. (Pubitemid 28509564)
45. Pittenger C, Duman RS (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33, 88-109. (Pubitemid 350191319)
46. Racagni G, Popoli M (2008). Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues in Clinical Neuroscience 10, 385-400.
47. Rajkowska G, Miguel-Hidalgo JJ (2007). Gliogenesis and glial pathology in depression. CNS & Neurological Disorders Drug Targets 6, 219-233. (Pubitemid 46916253)
48. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085-1098. (Pubitemid 29236550)
49. Schatzberg AF, Schildkraut JJ (1995). Recent Studies on Norepinephrine Systems in Mood Disorders. New York: Raven Press.
50. Schildkraut J (1965). The catecholamine hypothesis of affective disorders : A review of supporting evidence. American Journal of Psychiatry 122, 509-522.
51. Schinder AF, Poo M (2000). The neurotrophin hypothesis for synaptic plasticity. Trends in Neurosciences 23, 639-645. (Pubitemid 32007891)
52. Schmidt HD, Banasr M, Duman RS (2008). Future antidepressant targets : neurotrophic factors and related signaling cascades. Drug Discovery Today: Therapeutic Strategies 5, 151-156.
53. Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, et al. (2008). Serum markers support disease-specific glial pathology in major depression. Journal of Affective Disorders 111, 271-280.
54. Shenoy SK, Lefkowitz RJ (2003). Multifaceted roles of b-arrestins in the regulation of seven-membrane spanning receptor trafficking and signaling. Biochemical Journal 375, 503-515. (Pubitemid 37433499)
55. Stephen JP, Lefkowitz RJ (2002). Arresting developments in heptahelical receptor signaling and regulation. Trends in Cell Biology 12, 130-138. (Pubitemid 34164652)
56. Takebayashi M, Hisaoka K, Nishida A, Tsuchioka M, et al. (2006). Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. International Journal of Neuropsychopharmacology 9, 607-612. (Pubitemid 44607213)
57. Tardito D, Musazzi L, Tiraboschi E, Mallei A, et al. 2009 Early induction of CREB activation and CREB-regulating signalling by antidepressants International Journal of Neuropsychopharmacology 12 1367-1381.
58. Tardito D, Perez J, Tiraboschi E, Musazzi L, et al. (2006). Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants : A critical overview. Pharmacological Reviews 58, 115-134.
59. Verity AN, Wyatt TL, Hajos B, Eglen RM, et al. (1998). Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. Journal of Neurochemistry 70, 531-539. (Pubitemid 28079342)
60. Zhang X, Zhang Z, Xie C, Xi G, et al. (2008). Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32, 886-890. (Pubitemid 351312392)